These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 1382741)

  • 1. Cell membranes as barriers for antisense constructions.
    Budker VG; Knorre DG; Vlassov VV
    Antisense Res Dev; 1992; 2(2):177-84. PubMed ID: 1382741
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Cell membranes as a barrier during biological uses of antisense oligonucleotides, their derivatives, and analogs].
    Knoppe DG; Vlasov VV
    Bioorg Khim; 1992; 18(10-11):1330-40. PubMed ID: 1299216
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Binding of oligonucleotides to cell membranes at acidic pH.
    Goodarzi G; Watabe M; Watabe K
    Biochem Biophys Res Commun; 1991 Dec; 181(3):1343-51. PubMed ID: 1764085
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transport of oligonucleotides across natural and model membranes.
    Vlassov VV; Balakireva LA; Yakubov LA
    Biochim Biophys Acta; 1994 Jun; 1197(2):95-108. PubMed ID: 8031827
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Spontaneous entrapment of polynucleotides upon electrostatic interaction with ethanol-destabilized cationic liposomes.
    Maurer N; Wong KF; Stark H; Louie L; McIntosh D; Wong T; Scherrer P; Semple SC; Cullis PR
    Biophys J; 2001 May; 80(5):2310-26. PubMed ID: 11325732
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular and cellular barriers limiting the effectiveness of antisense oligonucleotides.
    Roth CM
    Biophys J; 2005 Oct; 89(4):2286-95. PubMed ID: 16055530
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Binding affinity and specificity of Escherichia coli RNase H1: impact on the kinetics of catalysis of antisense oligonucleotide-RNA hybrids.
    Lima WF; Crooke ST
    Biochemistry; 1997 Jan; 36(2):390-8. PubMed ID: 9003192
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Albumin-protamine-oligonucleotide-nanoparticles as a new antisense delivery system. Part 2: cellular uptake and effect.
    Weyermann J; Lochmann D; Georgens C; Zimmer A
    Eur J Pharm Biopharm; 2005 Apr; 59(3):431-8. PubMed ID: 15760723
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lipophilic oligonucleotides spontaneously insert into lipid membranes, bind complementary DNA strands, and sequester into lipid-disordered domains.
    Bunge A; Kurz A; Windeck AK; Korte T; Flasche W; Liebscher J; Herrmann A; Huster D
    Langmuir; 2007 Apr; 23(8):4455-64. PubMed ID: 17367171
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cationic lipids, phosphatidylethanolamine and the intracellular delivery of polymeric, nucleic acid-based drugs (review).
    Hope MJ; Mui B; Ansell S; Ahkong QF
    Mol Membr Biol; 1998; 15(1):1-14. PubMed ID: 9595549
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel cationic amphiphiles as delivery agents for antisense oligonucleotides.
    DeLong RK; Yoo H; Alahari SK; Fisher M; Short SM; Kang SH; Kole R; Janout V; Regan SL; Juliano RL
    Nucleic Acids Res; 1999 Aug; 27(16):3334-41. PubMed ID: 10454641
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficient encapsulation of antisense oligonucleotides in lipid vesicles using ionizable aminolipids: formation of novel small multilamellar vesicle structures.
    Semple SC; Klimuk SK; Harasym TO; Dos Santos N; Ansell SM; Wong KF; Maurer N; Stark H; Cullis PR; Hope MJ; Scherrer P
    Biochim Biophys Acta; 2001 Feb; 1510(1-2):152-66. PubMed ID: 11342155
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cationic vesicles based on non-ionic surfactant and synthetic aminolipids mediate delivery of antisense oligonucleotides into mammalian cells.
    Grijalvo S; Alagia A; Puras G; Zárate J; Pedraz JL; Eritja R
    Colloids Surf B Biointerfaces; 2014 Jul; 119():30-7. PubMed ID: 24859051
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Locked nucleic acids: a promising molecular family for gene-function analysis and antisense drug development.
    Orum H; Wengel J
    Curr Opin Mol Ther; 2001 Jun; 3(3):239-43. PubMed ID: 11497347
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Polyalkylcyanoacrylate nanoparticles as polymeric carriers for antisense oligonucleotides.
    Chavany C; Le Doan T; Couvreur P; Puisieux F; Hélène C
    Pharm Res; 1992 Apr; 9(4):441-9. PubMed ID: 1495887
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interactions of phosphodiester and phosphorothioate oligonucleotides with intestinal epithelial Caco-2 cells.
    Beck GF; Irwin WJ; Nicklin PL; Akhtar S
    Pharm Res; 1996 Jul; 13(7):1028-37. PubMed ID: 8842040
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modification of antisense phosphodiester oligodeoxynucleotides by a 5' cholesteryl moiety increases cellular association and improves efficacy.
    Krieg AM; Tonkinson J; Matson S; Zhao Q; Saxon M; Zhang LM; Bhanja U; Yakubov L; Stein CA
    Proc Natl Acad Sci U S A; 1993 Feb; 90(3):1048-52. PubMed ID: 8430072
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection of proteins binding to short RNA.DNA hybrids or short antisense oligonucleotides in Xenopus laevis oocytes and human macrophage cell extracts by photoaffinity radiolabeling.
    Revers F; Cario M; Cao TL; Cazenave C
    Antisense Nucleic Acid Drug Dev; 1999 Aug; 9(4):317-31. PubMed ID: 10463076
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Two problems in antisense biotechnology: in vitro delivery and the design of antisense experiments.
    Stein CA
    Biochim Biophys Acta; 1999 Dec; 1489(1):45-52. PubMed ID: 10806996
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficient cationic lipid-mediated delivery of antisense oligonucleotides into eukaryotic cells: down-regulation of the corticotropin-releasing factor receptor.
    Shi F; Nomden A; Oberle V; Engberts JB; Hoekstra D
    Nucleic Acids Res; 2001 May; 29(10):2079-87. PubMed ID: 11353077
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.